WuXi Biologics and Toregem BioPharma Sign MOU for Developmen

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Toregem...

Related Keywords

Germany , Japan , Shanghai , China , United States , Wuxi , Jiangsu , Singapore , Ireland , Kyoto , Toregem Biopharma , Honoka Kiso , Chris Chen , Inflamm Regen , Katsu Takahashi , Contract Research , Toregem Bio Pharma Co Ltd , Kyoto University , Manufacturing Organization , Wuxi Biologics , Wuxi Biologic , Investigational New Drug , Maxillofacial Surgery , Sci Adv ,